Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 41.92 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 35.85 | Oscillator | Neutral |
| Williams %R (14) | -54.31 | Oscillator | Neutral |
| MACD (12, 26, 9) | -3.56 (Hist 1.07) | Oscillator | Buy |
| Average Directional Index (14) | 24.29 (+DI 16.9 / -DI 30.3) | Trend | Sell |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 8, 26 | Mendelson Victor H | director, officer, other: Co-COB and Co-CEO | P-Purchase | 795 @ $220.30 | $175.1K |
| EMA 20 | 303.64 | MA | Sell |
| SMA 20 | 302.02 | MA | Sell |
| EMA 50 | 313.73 | MA | Strong Sell |
| SMA 50 | 317.30 | MA | Strong Sell |
| SMA 200 | 320.06 | MA | Strong Sell |
| Oct 8, 26 |
| Culligan Thomas M |
| director |
| P-Purchase |
| 795 @ $220.30 |
| $175.1K |
| Oct 8, 26 | Hildebrandt Mark H | director | P-Purchase | 795 @ $220.30 | $175.1K |
| Oct 8, 26 | Neitzel Julie | director | P-Purchase | 592 @ $294.93 | $174.6K |
| Oct 8, 26 | Fine Carol F. | director | P-Purchase | 795 @ $220.30 | $175.1K |
| Oct 8, 26 | Schriesheim Alan | director | P-Purchase | 795 @ $220.30 | $175.1K |
| Oct 8, 26 | Henriques Adolfo | director | P-Purchase | 795 @ $220.30 | $175.1K |
| Oct 8, 26 | Cheruvatath Nandakumar | director | P-Purchase | 795 @ $220.30 | $175.1K |
Stock news · updated daily
The consensus price target hints at a 26.8% upside potential for Heico (HEI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader market.
MIAMI, FL AND HOLLYWOOD, FL / ACCESS Newswire / October 13, 2026 / HEICO Corporation (NYSE:HEI.A)(NYSE:HEI) today reported that Eric A. Mendelson and Victor H.
HEI, ATI and TDY offer strong upside potential as defense demand, record backlogs and strategic acquisitions support growth.
Heico (HEI) could produce exceptional returns because of its solid growth attributes.
A $90,000 bag of screws reveals the brutal gap between how HEICO and TransDigm squeeze profit from the same captive market, but the company with the cleaner books and stronger moat carries a price that punishes anyone who buys it
Heico (HEI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GTN, VICR, EMBJ, WILYY and HEI have been added to the Zacks Rank #1 (Strong Buy) List on October 2, 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 25, 2026 | 1.52 | 1.67 | Beat 9.9% | $1.41B |
| May 27, 2026 | 1.33 | 1.66 | Beat 24.8% | $1.38B |
| Feb 25, 2026 | 1.28 | 1.35 | Beat 5.5% | $1.18B |
| Dec 18, 2025 | 1.22 | 1.33 | Beat 9.0% | $1.21B |
| Aug 25, 2025 | 1.13 | 1.26 | Beat 11.5% | $1.15B |
| May 27, 2025 | 1.03 | 1.12 | Beat 8.7% | $1.10B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 13, 2026 | 2026-10-13 15:33:35 | View |
| 4 | Oct 13, 2026 | 2026-10-13 15:32:49 | View |
| 4 | Oct 13, 2026 | 2026-10-13 15:31:45 | View |
| 4 | Oct 13, 2026 | 2026-10-13 15:30:38 | View |
| 4 | Oct 13, 2026 | 2026-10-13 15:29:32 | View |
| 4 | Oct 13, 2026 | 2026-10-13 15:28:11 | View |
| 4 | Oct 13, 2026 | 2026-10-13 15:27:07 | View |
| 4 | Oct 13, 2026 | 2026-10-13 15:25:45 | View |
| 4 | Sep 1, 2026 | 2026-09-01 15:08:35 | View |
| 10-Q | Aug 27, 2026 | 2026-08-27 16:10:57 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | HEI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 49.2x | 61.6x · sector 18.4x | Elevated |
| Forward P/E (FY26E) | 47.2x | EPS est. 6.34 | In line |
| Price / Book | 8.4x | 8.6x | In line |
| Price / Sales | 8.0x | 9.2x | In line |
| EV / EBITDA | 30.0x | 36.3x | Discount |
| Return on equity | 18.3% | — | Healthy |
| Gross margin | 40.4% | 41.8% | In line |
| Debt / Equity | 0.51 | 0.43 | Moderate |
| Piotroski / Altman Z | 6/9 | Z 7.55 | Safe zone |
Discounted cash flow model
Current price $298.96
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 19, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Oct 9, 26 | TD Cowen | maintain | Hold | Hold |
| Sep 30, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Sep 2, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Aug 28, 26 | Citigroup | maintain | Buy | Buy |
| Aug 27, 26 | Jefferies | maintain | Buy | Buy |
| Aug 27, 26 | UBS | maintain | Neutral | Neutral |
| Aug 19, 26 | Deutsche Bank | maintain | Buy | Buy |
| Aug 13, 26 | Citigroup | maintain | Buy | Buy |